Answers are grounded in this paper and cite their sources.
Long-term kidney outcomes in patients with diabetic eye disease were similar in placebo and RBX groups. In conclusion, large-scale, prospective trials in patients with diabetic nephropathy are needed to confirm safety and potential benefits of RBX on clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Tuttle et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: